High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2026Q1
189.33M
+13.59%
0.054
-63.84%
188.09M
+13.01%
0.146
+12.56%
Estimates Revision
The market is revising Upward the revenue expectations for Appian Corporation (APPN) for FY2025, with the revenue forecasts being adjusted by 2.14% over the past three months. During the same period, the stock price has changed by 28.85%.
Revenue Estimates for FY2025
Revise Upward
+2.14%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+64.3%
In Past 3 Month
Stock Price
Go Up
+28.85%
In Past 3 Month
6 Analyst Rating
Wall Street analysts forecast APPN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for APPN is 39.40 USD with a low forecast of 37.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
4 Hold
2 Sell
Moderate Sell
Current: 39.390
Low
37.00
Averages
39.40
High
45.00
Current: 39.390
Low
37.00
Averages
39.40
High
45.00
Morgan Stanley
Sanjit Singh
Equal Weight
maintain
$29 -> $45
2025-11-11
Reason
Morgan Stanley
Sanjit Singh
Price Target
$29 -> $45
2025-11-11
maintain
Equal Weight
Reason
Morgan Stanley analyst Sanjit Singh raised the firm's price target on Appian to $45 from $29 and keeps an Equal Weight rating on the shares. The firm raised estimates following Q3 results and rolls forward its valuation year to 2027, the analyst tells investors.
Barclays
Underweight
maintain
$33 -> $37
2025-11-07
Reason
Barclays
Price Target
$33 -> $37
2025-11-07
maintain
Underweight
Reason
Barclays raised the firm's price target on Appian to $37 from $33 and keeps an Underweight rating on the shares. The firm sees the company's Q3 results attracting more investor interest. The quarter saw another "healthy revenue beat and raise" and importantly, Appian's U.S. federal segment growth was robust, the analyst tells investors in a research note.
TD Cowen
Hold
downgrade
$37 -> $35
2025-08-08
Reason
TD Cowen
Price Target
$37 -> $35
2025-08-08
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Appian to $35 from $37 and keeps a Hold rating on the shares. The firm said they posted Cloud growth of 18% cc, as Fed demand has been stable and likely a source of billings strength, and AI engagements are showing early traction.
Barclays
Equal Weight
maintain
$50 -> $58
2025-07-23
Reason
Barclays
Price Target
$50 -> $58
2025-07-23
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Pegasystems (PEGA) to $58 from $50 and keeps an Equal Weight rating on the shares. Following what the firm describes as "another quarter of above consensus growth," it adds that Q2 was "almost better compared to Q1 when looking at the quality of the beat." While stating that it is "getting clearer" that the genAI Blueprint offering is "starting to work well as a demand generation tool," the firm keeps an Equal Weight rating as it does more work on the ultimate total addressable market and Appian's (APPN) lawsuit.
Citi
Buy
maintain
$40 -> $41
2025-05-13
Reason
Citi
Price Target
$40 -> $41
2025-05-13
maintain
Buy
Reason
Citi raised the firm's price target on Appian to $41 from $40 and keeps a Buy rating on the shares. The firm notes Appian reported better-than-feared Q1 results, with a healthy 1.9% top-line beat and $7.6M EBITDA beat partly flowed through to the raised/widened full year guides. Management noted no macro impacts to pipeline or sales cycles so far, including the Fed biz that had an especially strong bookings quarter with cautious optimism for the remainder of the year. Citi also points out that AI monetization is progressing with the new Advanced tier driving $9M in revenue for the quarter despite still early innings on the back-to-base upgrade cycle. The firm is encouraged by the Fed results/outlook, progress on AI monetization, and margin upside.
Barclays
Underweight
maintain
$28 -> $33
2025-05-09
Reason
Barclays
Price Target
$28 -> $33
2025-05-09
maintain
Underweight
Reason
Barclays raised the firm's price target on Appian to $33 from $28 and keeps an Underweight rating on the shares. The company reported solid Q1 results and its raised fiscal year guidance shows optimism in its growth, which should be enough to move shares higher in the short term, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Appian Corp (APPN.O) is 70.60, compared to its 5-year average forward P/E of -125.67. For a more detailed relative valuation and DCF analysis to assess Appian Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-125.67
Current PE
70.60
Overvalued PE
167.93
Undervalued PE
-419.27
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
136.39
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1007.64
Undervalued EV/EBITDA
-734.86
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
8.99
Current PS
0.00
Overvalued PS
17.64
Undervalued PS
0.34
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
APPN News & Events
Events Timeline
(ET)
2025-11-06
07:37:32
Appian projects FY25 EPS between 50c and 54c, surpassing consensus estimate of 33c.
2025-11-06
07:37:00
Appian projects Q4 EPS between 4c and 8c, while consensus estimates at 13c
2025-11-06
07:35:47
Appian Announces Q3 Earnings Per Share of 10 Cents, Exceeding Consensus Estimate of 5 Cents
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/20251205052023_f4e3e41a259e154559ba7e70237ea8b7.jpeg)
Preview
1.0
05:20 AMGlobenewswireAppian CFO Serge Tanjga to Present at Barclays 23rd Annual Global Technology Conference
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/newsfilter.png)
Preview
1.0
11-21NewsfilterAppian Announces Winners of 2025 Public Sector Partner Awards
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/9f9276dab6265db1a27732548d33b913d870fdde8cda62cf83ba8d4f814e6fcf.png)
Preview
3.5
11-20PRnewswireAppian AI Transforms Clinical Workflows for Global Public Health Agencies
Sign Up For More News
People Also Watch
FAQ
What is Appian Corp (APPN) stock price today?
What is Appian Corp (APPN)'s business?
What is the price predicton of APPN Stock?
What is Appian Corp (APPN)'s revenue for the last quarter?
What is Appian Corp (APPN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Appian Corp (APPN)'s fundamentals?
How many employees does Appian Corp (APPN). have?